News

Certain pain-related pruritus descriptors may independently predict mental health outcomes, sleep disturbance, and QOL reduction in patients with AD.
Patients with chronic itching often cannot focus their attention on anything else. Psychologists want to help them, but they ...
The two-dose vaccine has been shown to have benefits beyond just developing shingles, although that alone should be impetus ...
Finding an effective, safe medication to control itch is essential to maximize patient comfort. Because Zenrelia does not require a loading dose and is administered once daily, Zenrelia may help impro ...
As the months dragged on, it became clear something was seriously wrong. By then, over a year-and-a-half had passed. I had ...
Skin grafts genetically engineered from a patient's own cells can heal persistent wounds in people with an extremely painful ...
Galderma Initiates Two New Clinical Trials Investigating Nemolizumab in Patients With Systemic Sclerosis and Chronic Pruritus of Unknown Origin ...
Skin grafts genetically engineered from a patient’s own cells can heal persistent wounds in people with an extremely painful ...
On top of the discomfort, vaginal itching can cause a lot of anxiety as you wonder what could be wrong, especially if it's ...
The FDA has accepted for review the NDA for linerixibat for the treatment of cholestatic pruritus in patients with primary biliary cholangitis.
GSK's marketing application for linerixibat, targeting cholestatic pruritus in PBC patients, gains EMA acceptance based on phase III success.
EMA accepts GSK’s MAA for linerixibat for cholestatic pruritus in patients with primary biliary cholangitis: London, UK Tuesday, June 24, 2025, 09:00 Hrs [IST] GSK plc announced ...